Please use this identifier to cite or link to this item: https://doi.org/10.1016/j.ejheart.2006.10.022
Title: Angiopoietin-1 for myocardial angiogenesis: A comparison between delivery strategies
Authors: Ye, L. 
Toh, W.C.
Haider, H.K.
Jiang, S.
Tan, R.S.
Ge, R. 
Sim, E.K.W. 
Keywords: Angiogenesis
Angiopoietin-1
Ischaemia
Myoblast
Issue Date: 2007
Source: Ye, L., Toh, W.C., Haider, H.K., Jiang, S., Tan, R.S., Ge, R., Sim, E.K.W. (2007). Angiopoietin-1 for myocardial angiogenesis: A comparison between delivery strategies. European Journal of Heart Failure 9 (5) : 458-465. ScholarBank@NUS Repository. https://doi.org/10.1016/j.ejheart.2006.10.022
Abstract: We compare the effectiveness of direct adenoviral angiopoietin-1 (Ad-Ang-1) injection with transplantation of skeletal myoblasts (SkMs) over-expressing angiopoietin-1 (Ang-1) for angiogenic response and improvement of heart function in an experimental porcine model of myocardial infarction (MI). Methods: Ad-Ang-1 was used for intramyocardial injection or transduction of SkMs. Three weeks after coronary artery ligation in 32 female pigs, animals were grouped to receive multiple intramyocardial injections of DMEM without cells (group-1; n = 7), or containing 3 × 108 Lac-z labelled SkMs transduced with Ad-Null vector carrying no gene (group-2; n = 7), or 1 × 1010 PFU Ad-Ang-1 (group-3; n = 9), or 3 × 108 Lac-z labelled SkMs transduced with Ad-Ang-1 (group-4; n = 9). The animals were immunosuppressed for 6-weeks. After euthanasia, their heart tissue was processed for histological studies. Results: Extensive survival of Lac-z positive SkMs was observed in and around the infarct 6 and 12-weeks after transplantation. Fluorescent immunostaining for vWF-VIII at 6-weeks revealed increased blood vessel density (× 100) in group-4 (p < 0.05) as compared with other groups. Regional blood flow (ml/g/min) in the peri-infarct area was improved in group-4 (2.7; p < 0.05) as compared with group-1 (1.2 ± 0.1), group-2 (1.1 ± 0.4) and group-3 (1.7 ± 0.1) at 6-weeks. Similarly, ejection fraction was significantly higher in group-4 (49.2 ± 5.9%, p = 0.03) as compared with group-1 (36.8 ± 3%) at 6 weeks. Conclusion: SkMs mediated Ang-1 delivery is associated with improved angiogenic response, regional myocardial perfusion and heart function as compared with direct Ad-Ang-1 administration. © 2006 European Society of Cardiology.
Source Title: European Journal of Heart Failure
URI: http://scholarbank.nus.edu.sg/handle/10635/30190
ISSN: 13889842
DOI: 10.1016/j.ejheart.2006.10.022
Appears in Collections:Staff Publications

Show full item record
Files in This Item:
There are no files associated with this item.

SCOPUSTM   
Citations

17
checked on Dec 5, 2017

WEB OF SCIENCETM
Citations

15
checked on Dec 5, 2017

Page view(s)

191
checked on Dec 11, 2017

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.